# DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

> **NCT02070965** · PHASE2 · COMPLETED · sponsor: **Primus Pharmaceuticals** · enrollment: 75 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** DFD01 Spray
- **DRUG:** Comp01 Lotion

## Key facts

- **NCT ID:** NCT02070965
- **Lead sponsor:** Primus Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2024-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02070965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02070965, "DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02070965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*